Fig. 3
From: New benzimidazole-triazole glycoconjugates as anti-cancer agents and EGFR inhibitors

The synthetic route toward the targeted conjugates 2-10b.
From: New benzimidazole-triazole glycoconjugates as anti-cancer agents and EGFR inhibitors

The synthetic route toward the targeted conjugates 2-10b.